Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

WEUSKOP5522: Observational Drug Exposure Registry for Long-Term Follow-Up of Subjects Exposed to GSK2248761

NCT01458132 is registered in ClinicalTrials.gov with ViiV Healthcare as lead sponsor.

NCT NCT01458132
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01458132 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
WEUSKOP5522: Observational Drug Exposure Registry for Long-Term Follow-Up of Subjects Exposed to GSK2248761
Lead sponsor
ViiV Healthcare
Phase
Observational
Overall status
Completed
Start date
July 29, 2011
Completion date
April 30, 2013
Enrollment
19 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

hiv infections